Advertisement

Submit Manuscripts
Author Information
Subscribe/Renew
Order Reprints
Email Alerts
Feedback
RSS Feed
CME

About the Journal
Editorial Board & Staff

JACC Imaging Homepage JACC Interventions Homepage
Still not a subscriber to JACC Imaging or JACC Interventions?
Click here
to sign up now!

ACC.org
Cardiosmart
Cardiosource
CVN
Imaging Library
JACC Imaging
JACC Interventions

Click here for more guidelines.
ACCF/ASNC/ACR/
AHA/ASE/SCCT/
SCMR/SNM 2009 Appropriate Use Criteria for Cardiac Radionuclide Imaging
SCIENCE ADVISORY: Percutaneous Device Closure of Patent Foramen Ovale for Secondary Stroke Prevention
ACCF/AHA 2009 Expert Consensus Document on Pulmonary Hypertension
CME Topic Collections Past Issues Search Current Issue Home
     

J Am Coll Cardiol, 2000; 35:56-59
© 2000 by the American College of Cardiology Foundation
This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Gottlieb, S. S.
Right arrow Articles by Liittschwager, E. B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Gottlieb, S. S.
Right arrow Articles by Liittschwager, E. B.

CLINICAL STUDIES

Effects of BG9719 (CVT-124), an A1-Adenosine receptor antagonist, and furosemide on glomerular filtration rate and natriuresis in patients with congestive heart failure

Stephen S. Gottlieb, MD, FACC*, Sandra L. Skettino, MD{dagger}, Andrew Wolff, MD{dagger}, Evan Beckman, MD{ddagger}, Michael L. Fisher, MD, FACC*, Ronald Freudenberger, MD, FACC*, Tim Gladwell, PharmD*, Joanne Marshall, RN*, Michelle Cines, RN*, Donald Bennett, PhD{ddagger} and Elizabeth B. Liittschwager, BA{dagger}

* Division of Cardiology, Department of Medicine, University of Maryland School of Medicine, Baltimore, Maryland, USA and the D.V.A. Medical Center, Baltimore, Maryland
{dagger} CV Therapeutics, Palo Alto, California, USA
{ddagger} Biogen, Cambridge, Massachusetts, USA

Manuscript received December 31, 1998; revised manuscript received July 29, 1999, accepted October 5, 1999.

Reprint requests and correspondence: Dr. Stephen S. Gottlieb, Division of Cardiology, University of Maryland School of Medicine, 22 South Greene Street, Baltimore, Maryland 21201
sgottlie{at}medicine.umaryland.edu

OBJECTIVES

To determine the effects of furosemide and the selective A1 adenosine receptor BG9719 on renal function in patients with congestive heart failure (CHF).

BACKGROUND

Studies suggest that adenosine may affect renal function by various mechanisms, but the effects of blockade of this system in humans is unknown. In addition, the effects of a therapeutic dose of furosemide on glomerular filtration rate (GFR) and renal plasma flow (RPF) in heart failure patients are controversial.

METHODS

On different days, 12 patients received placebo, BG9719 and furosemide. Glomerular filtration rate, RPF and sodium and water excretion were assessed immediately following drug administration.

RESULTS

Glomerular filtration rate was 84 ± 23 ml/min/1.73m2 after receiving placebo, 82 ± 24 following BG9719 administration and a decreased (p < 0.005) 63 ± 18 following furosemide. Renal plasma flow was unchanged at 293 ± 124 ml/min/1.73m2 on placebo, 334 ± 155 after receiving BG9719 and 374 ± 231 after receiving furosemide. Sodium excretion increased from 8 ± 8 mEq following placebo administration to 37 ± 26 mEq following BG9719 administration. In the six patients in whom it was measured, sodium excretion was 104 ± 78 mEq following furosemide administration.

CONCLUSIONS

Natriuresis is effectively induced by both furosemide and the adenosine A1 antagonist BG9719 in patients with CHF. Doses of the two drugs used in this study did not cause equivalent sodium and water excretion but only furosemide decreased GFR. These data suggest that adenosine is an important determinant of renal function in patients with heart failure.

Abbreviations and Acronyms
  CHF = congestive heart failure
  GFR = glomerular filtration rate
  RPF = renal plasma flow




This article has been cited by other articles:


Home page
 HeartHome page
A Kazory and E A Ross
Ultrafiltration for decompensated heart failure: renal implications
Heart, July 1, 2009; 95(13): 1047 - 1051.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Renal Physiol.Home page
A. Kulick, C. Panico, P. Gill, and W. J. Welch
Low salt intake increases adenosine type 1 receptor expression and function in the rat proximal tubule
Am J Physiol Renal Physiol, July 1, 2008; 295(1): F37 - F41.
[Abstract] [Full Text] [PDF]

Home page
 Eur J Heart FailHome page
V. Vallon, C. Miracle, and S. Thomson
Adenosine and kidney function: Potential implications in patients with heart failure
Eur J Heart Fail, February 1, 2008; 10(2): 176 - 187.
[Abstract] [Full Text] [PDF]

Home page
 Eur J Heart FailHome page
L. De Luca, A. Mebazaa, G. Filippatos, J. T. Parissis, M. Bohm, A. A. Voors, M. Nieminen, F. Zannad, A. Rhodes, A. El-Banayosy, et al.
Overview of emerging pharmacologic agents for acute heart failure syndromes
Eur J Heart Fail, February 1, 2008; 10(2): 201 - 213.
[Abstract] [Full Text] [PDF]

Home page
 J Am Coll CardiolHome page
B. Greenberg, I. Thomas, D. Banish, S. Goldman, E. Havranek, B. M. Massie, Y. Zhu, B. Ticho, and W. T. Abraham
Effects of Multiple Oral Doses of an A1 Adenosine Antagonist, BG9928, in Patients With Heart Failure: Results of a Placebo-Controlled, Dose-Escalation Study
J. Am. Coll. Cardiol., August 14, 2007; 50(7): 600 - 606.
[Abstract] [Full Text] [PDF]

Home page
 J Am Coll CardiolHome page
E. M. deGoma, R. H. Vagelos, M. B. Fowler, and E. A. Ashley
Emerging Therapies for the Management of Decompensated Heart Failure: From Bench to Bedside
J. Am. Coll. Cardiol., December 19, 2006; 48(12): 2397 - 2409.
[Abstract] [Full Text] [PDF]

Home page
 Eur J Heart FailHome page
F. Zannad, A. Mebazaa, Y. Juilliere, A. Cohen-Solal, L. Guize, F. Alla, P. Rouge, P. Blin, M.-H. Barlet, L. Paolozzi, et al.
Clinical profile, contemporary management and one-year mortality in patients with severe acute heart failure syndromes: The EFICA study
Eur J Heart Fail, November 1, 2006; 8(7): 697 - 705.
[Abstract] [Full Text] [PDF]

Home page
 Physiol. Rev.Home page
V. Vallon, B. Muhlbauer, and H. Osswald
Adenosine and kidney function.
Physiol Rev, July 1, 2006; 86(3): 901 - 940.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
R. D. Brown, P. Thoren, A. Steege, R. Mrowka, J. Sallstrom, O. Skott, B. B. Fredholm, and A. E. G. Persson
Influence of the adenosine A1 receptor on blood pressure regulation and renin release
Am J Physiol Regulatory Integrative Comp Physiol, May 1, 2006; 290(5): R1324 - R1329.
[Abstract] [Full Text] [PDF]

Home page
 CirculationHome page
D. J. Wang, T. C. Dowling, D. Meadows, T. Ayala, J. Marshall, S. Minshall, N. Greenberg, E. Thattassery, M. L. Fisher, K. Rao, et al.
Nesiritide Does Not Improve Renal Function in Patients With Chronic Heart Failure and Worsening Serum Creatinine
Circulation, September 21, 2004; 110(12): 1620 - 1625.
[Abstract] [Full Text] [PDF]

Home page
 J. Pharmacol. Exp. Ther.Home page
J. A. Auchampach, X. Jin, J. Moore, T. C. Wan, L. M. Kreckler, Z.-D. Ge, J. Narayanan, E. Whalley, W. Kiesman, B. Ticho, et al.
Comparison of Three Different A1 Adenosine Receptor Antagonists on Infarct Size and Multiple Cycle Ischemic Preconditioning in Anesthetized Dogs
J. Pharmacol. Exp. Ther., March 1, 2004; 308(3): 846 - 856.
[Abstract] [Full Text] [PDF]

Home page
 Journal of Renin-Angiotensin-Aldosterone SystemHome page
K. H Chee, K. Amudha, N. A Hussain, H. K Haizal, A.-M. J Choy, and C. C Lang
Combination of drugs acting on the natriuretic system and the renin-angiotensin system in heart failure
Journal of Renin-Angiotensin-Aldosterone System, September 1, 2003; 4(3): 140 - 148.
[Abstract] [PDF]

Home page
 HeartHome page
J J V McMurray
Heart failure in 10 years time: focus on pharmacological treatment
Heart, October 1, 2002; 88(90002): ii40 - 46.
[Full Text] [PDF]

Home page
 Am. J. Physiol. Renal Physiol.Home page
E. K. Jackson, C. Zhu, and S. P. Tofovic
Expression of adenosine receptors in the preglomerular microcirculation
Am J Physiol Renal Physiol, July 1, 2002; 283(1): F41 - F51.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Pathol.Home page
M. C. Montesinos, A. Desai, J.-F. Chen, H. Yee, M. A. Schwarzschild, J. S. Fink, and B. N. Cronstein
Adenosine Promotes Wound Healing and Mediates Angiogenesis in Response to Tissue Injury Via Occupancy of A2A Receptors
Am. J. Pathol., June 1, 2002; 160(6): 2009 - 2018.
[Abstract] [Full Text] [PDF]

Home page
 CirculationHome page
J. McMurray and M. A. Pfeffer
New Therapeutic Options in Congestive Heart Failure: Part I
Circulation, April 30, 2002; 105(17): 2099 - 2106.
[Full Text] [PDF]

Home page
 CirculationHome page
S. S. Gottlieb, D. C. Brater, I. Thomas, E. Havranek, R. Bourge, S. Goldman, F. Dyer, M. Gomez, D. Bennett, B. Ticho, et al.
BG9719 (CVT-124), an A1 Adenosine Receptor Antagonist, Protects Against the Decline in Renal Function Observed With Diuretic Therapy
Circulation, March 19, 2002; 105(11): 1348 - 1353.
[Abstract] [Full Text] [PDF]

Home page
 J Am Coll CardiolHome page
L. M. Ruilope, D. J. van Veldhuisen, E. Ritz, and T. F. Luscher
Renal function: the Cinderella of cardiovascular risk profile
J. Am. Coll. Cardiol., December 1, 2001; 38(7): 1782 - 1787.
[Abstract] [Full Text] [PDF]

Home page
 J. Pharmacol. Exp. Ther.Home page
E. K. Jackson, C. K. Kost Jr., W. A. Herzer, G. J. Smits, and S. P. Tofovic
A1 Receptor Blockade Induces Natriuresis with a Favorable Renal Hemodynamic Profile in SHHF/Mcc-facp Rats Chronically Treated with Salt and Furosemide
J. Pharmacol. Exp. Ther., December 1, 2001; 299(3): 978 - 987.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Renal Physiol.Home page
E. K. Jackson and R. K. Dubey
Role of the extracellular cAMP-adenosine pathway in renal physiology
Am J Physiol Renal Physiol, October 1, 2001; 281(4): F597 - F612.
[Abstract] [Full Text] [PDF]

Home page
 JAMAHome page
J. Al Suwaidi, P. B. Berger, and D. R. Holmes Jr
Coronary Artery Stents
JAMA, October 11, 2000; 284(14): 1828 - 1836.
[Abstract] [Full Text] [PDF]


 
  CME Topic Collections Past Issues Search Current Issue Home

Advertisement